These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1721280)

  • 21. Effects of twenty-three drugs on the metabolism of FK506 by human liver microsomes.
    Iwasaki K; Matsuda H; Nagase K; Shiraga T; Tokuma Y; Uchida K
    Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):209-16. PubMed ID: 7508138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of FK506 (tacrolimus) with clinically important drugs.
    Matsuda H; Iwasaki K; Shiraga T; Tozuka Z; Hata T; Guengerich FP
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):57-64. PubMed ID: 8824931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of phenobarbital, 3-methylcholanthrene, and griseofulvin on the O-demethylation of griseofulvin by liver microsomes of rats and mice.
    Lin C; Chang R; Casmer C; Symchowicz S
    Drug Metab Dispos; 1973; 1(4):611-8. PubMed ID: 4149634
    [No Abstract]   [Full Text] [Related]  

  • 25. Species differences in the induction of microsomal hemoproteins and 3,4-benzpyrene hydroxylase by phenobarbital and 3-methylcholanthrene.
    Alvares AP; Schilling G; Levin W
    J Pharmacol Exp Ther; 1970 Oct; 175(1):4-11. PubMed ID: 5471452
    [No Abstract]   [Full Text] [Related]  

  • 26. Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes.
    Alvares AP; Mannering GJ
    Mol Pharmacol; 1970 May; 6(3):206-12. PubMed ID: 5443528
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of phenobarbital, 3-methylcholanthrene, and pregnenolone-16 alpha-carbonitrile on the N-demethylation and O-de-ethylation of [6-H3]ethylmorphine.
    Duquette PH; Peterson FJ; Erickson RR; Holtzman JL
    Drug Metab Dispos; 1981; 9(5):483-4. PubMed ID: 6117451
    [No Abstract]   [Full Text] [Related]  

  • 28. Benznidazole and nifurtimox nitroreductase activity in liver microsomes from male rats preinduced with phenobarbital or 3-methylcholanthrene.
    Aguilar EG; de Arranz CK; de Toranzo EG; Castro JA
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):443-6. PubMed ID: 3841223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of antiparkinson agent dopazinol by rat liver microsomes.
    Vyas KP; Kari PH; Ramjit HG; Pitzenberger SM; Hichens M
    Drug Metab Dispos; 1990; 18(6):1025-30. PubMed ID: 1981508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between FK 506 and cyclosporine in dogs.
    Wu YM; Venkataramanan R; Suzuki M; Zhu Y; Abdallah H; Emeigh J; Burckart GJ; Warty VS; Fung JJ; Todo S
    Transplant Proc; 1991 Dec; 23(6):2797-9. PubMed ID: 1721281
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic efficacy of cyclophosphamide as a function of its metabolism.
    Sladek NE
    Cancer Res; 1972 Mar; 32(3):535-42. PubMed ID: 5061308
    [No Abstract]   [Full Text] [Related]  

  • 32. The formation of carbamazepine epoxide by rat liver microsomes: an investigation of the biphasic kinetic profile.
    van Boxtel CJ; Rane A; Brown RD; Wilson JT
    Life Sci; 1981 Dec; 29(25):2575-84. PubMed ID: 7321777
    [No Abstract]   [Full Text] [Related]  

  • 33. FK 506 inhibition of cyclosporine metabolism by human liver microsomes.
    Omar G; Shah IA; Thomson AW; Whiting PH; Burke MD
    Transplant Proc; 1991 Feb; 23(1 Pt 2):934-5. PubMed ID: 1703356
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes.
    Jaeger W; Benet LZ; Bornheim LM
    Xenobiotica; 1996 Mar; 26(3):275-84. PubMed ID: 8730919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro interaction between cyclosporin A and macrolide antibiotics.
    Marre F; de Sousa G; Orloff AM; Rahmani R
    Br J Clin Pharmacol; 1993 Apr; 35(4):447-8. PubMed ID: 8485028
    [No Abstract]   [Full Text] [Related]  

  • 36. The yin and yang of lidocaine and cyclosporine metabolism in liver graft recipients.
    Christians U; Kohlhaw K; Esselmann H; Sürig T; Luy M; Kaltefleiter M; Beyrau R; Linck A; Ringe B; Oellerich M
    Transplant Proc; 1994 Oct; 26(5):2827-8. PubMed ID: 7940891
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of the metabolism of cyclosporine by human liver microsomes by FK506.
    Burke MD; Omar G; Thomson AW; Whiting RH
    Transplantation; 1990 Nov; 50(5):901-2. PubMed ID: 1700507
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro effects of cyclosporine and FK 506 on the renal cortex.
    Prasad SJ; McCauley J; Salama G; Starzl TE; Murray SA
    Transplant Proc; 1991 Dec; 23(6):3128-9. PubMed ID: 1721380
    [No Abstract]   [Full Text] [Related]  

  • 39. 15-Desmethyl FK-506 and 15,31-desmethyl FK-506 from human liver microsomes: isolation, identification (by fast atom bombardment mass spectrometry and NMR), and evaluation of in vitro immunosuppressive activity.
    Lhöest GJ; Maton N; Latinne D; Laurent A; Verbeeck RK
    Clin Chem; 1994 May; 40(5):740-4. PubMed ID: 7513627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and identification of a FK-506 C36-C37 dihydrodiol from erythromycin-induced rabbit liver microsomes.
    Lhoëst G; Maton N; Laurent A; Verbeeck RK
    J Pharm Biomed Anal; 1994 Feb; 12(2):235-41. PubMed ID: 7516189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.